Pfizer’s RSV Vaccine: US FDA Panel Wants Robust Safety Program With Public Accountability

Advisory committee offers strong support for approval of Pfizer’s RSV vaccine to protect infants while simultaneously offering the agency a handful of suggestions that were directed towards the review and post-market surveillance of all vaccinations.